Partners Capital Investment Group, LLP Kronos Bio, Inc. Transaction History
Partners Capital Investment Group, LLP
- $5.57 Billion
- Q1 2025
A detailed history of Partners Capital Investment Group, LLP transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Partners Capital Investment Group, LLP holds 1,448,654 shares of KRON stock, worth $1.01 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,448,654
Previous 527,500
174.63%
Holding current value
$1.01 Million
Previous $501,000
136.93%
% of portfolio
0.02%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding KRON
# of Institutions
49Shares Held
19.4MCall Options Held
51.2KPut Options Held
0-
Vida Ventures Advisors, LLC2.77MShares$1.94 Million44.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.35 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.01 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.43MShares$997,5450.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.35MShares$941,7890.07% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $39.7M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...